Alpharix-Tetra

Alpharix-Tetra is a vaccine designed to protect against influenza viruses, including B/Phuket/3073/2013-like virus and Influenza Virus B/Austria/1359417/202. It is administered intramuscularly and is manufactured by GlaxoSmithKline Biologicals S.A.

Alpharix-Tetra is used for the prevention of influenza caused by specific virus strains. This vaccine is intended to help the body build immunity against these influenza viruses, reducing the risk of infection and severe illness. It is commonly recommended for individuals who are at higher risk of complications from influenza.

After receiving Alpharix-Tetra, some individuals may experience common effects such as soreness at the injection site, mild fever, or fatigue. These effects are typically temporary and resolve on their own. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Alpharix-Tetra should be stored and handled according to the manufacturer's guidelines to maintain its effectiveness. Individuals with known allergies to any components of the vaccine should avoid its use. It is essential to inform healthcare providers about any pre-existing conditions or medications before receiving this vaccine.

Alpharix-Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Alpharix-Tetra. Alcohol and other substances that affect the immune system should be considered when planning vaccination.